{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,19]],"date-time":"2025-10-19T09:21:36Z","timestamp":1760865696250},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2011,12,11]],"date-time":"2011-12-11T00:00:00Z","timestamp":1323561600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Hepatol Int"],"published-print":{"date-parts":[[2012,10]]},"DOI":"10.1007\/s12072-011-9326-3","type":"journal-article","created":{"date-parts":[[2011,12,10]],"date-time":"2011-12-10T07:53:10Z","timestamp":1323503590000},"page":"790-795","source":"Crossref","is-referenced-by-count":3,"title":["Complete spectrum of AMA-M2 positive liver disease in north India"],"prefix":"10.1007","volume":"6","author":[{"given":"Ranjana W.","family":"Minz","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Navchetan","family":"Kaur","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shashi","family":"Anand","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ritu","family":"Aggarwal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Biman","family":"Saikia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ashim","family":"Das","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yogesh K.","family":"Chawla","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2011,12,11]]},"reference":[{"key":"9326_CR1","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1055\/s-2007-979469","volume":"27","author":"P Invernizzi","year":"2007","unstructured":"Invernizzi P, Lleo A, Podda M. Interpreting serological tests in diagnosing autoimmune liver diseases. Semin Liver Dis 2007;27:161\u2013172","journal-title":"Semin Liver Dis"},{"key":"9326_CR2","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1055\/s-2002-34506","volume":"22","author":"H Ishibashi","year":"2002","unstructured":"Ishibashi H, Shimoda S, Gershwin ME. The immune response to mitochondrial autoantigens. Semin Liver Dis 2002;22:291\u2013302","journal-title":"Semin Liver Dis"},{"key":"9326_CR3","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1055\/s-2002-34506","volume":"22","author":"A Nishio","year":"2002","unstructured":"Nishio A, Keeffe EB, Gershwin ME. Immunopathogenesis of primary biliary cirrohosis. Semin Liver Dis 2002;22:291\u2013302","journal-title":"Semin Liver Dis"},{"key":"9326_CR4","doi-asserted-by":"crossref","first-page":"1399","DOI":"10.1016\/S0140-6736(96)04410-8","volume":"348","author":"JV Metcalf","year":"1996","unstructured":"Metcalf JV, Mitchison HC, Palmer JM, Jones DE, Bassendine MF, James OFW. Natural history of early primary biliary cirrohosis. Lancet 1996;348:1399\u20131402","journal-title":"Lancet"},{"key":"9326_CR5","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1016\/S0168-8278(00)00040-4","volume":"34","author":"P Invernizzi","year":"2001","unstructured":"Invernizzi P, Podda M, Battezzati PM, Crosignani A, Zuin M, Hitchman E, et al. Autoantibodies against nuclear pore complexes are associated with more active and severe liver disease in primary biliary cirrhosis. J Hepatol 2001;34:366\u2013372","journal-title":"J Hepatol"},{"key":"9326_CR6","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/S1665-2681(19)32061-7","volume":"4","author":"P Charatcharoenwittaya","year":"2005","unstructured":"Charatcharoenwittaya P, Lindor KD. Current concepts in the pathogenesis of primary biliary cirrhosis. Ann Hepatol 2005;4:161\u2013175","journal-title":"Ann Hepatol"},{"key":"9326_CR7","doi-asserted-by":"crossref","first-page":"3328","DOI":"10.3748\/wjg.14.3328","volume":"14","author":"A Lleo","year":"2008","unstructured":"Lleo A, Invernizzi P, Mackay IR, Prince H, Zhong RQ, Gershwin ME. Etiopathogenesis of primary biliary cirrhosis. World J Gasteroenterol 2008;14:3328\u20133337","journal-title":"World J Gasteroenterol"},{"key":"9326_CR8","doi-asserted-by":"crossref","first-page":"3313","DOI":"10.3748\/wjg.14.3313","volume":"14","author":"A Crosignani","year":"2008","unstructured":"Crosignani A, Battezatti PM, Invernizzi P, Selmi C, Prina E, Podda M. Clinical management of primary biliary cirrhosis. World J Gasteroenterol 2008;14:3313\u20133327","journal-title":"World J Gasteroenterol"},{"key":"9326_CR9","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1080\/10446670410001722113","volume":"11","author":"GD Bensen","year":"2004","unstructured":"Bensen GD, Kikuchi K, Miyakawa H, Tanaka A, Watnik MR, Gershwin ME. Serial analysis of antimitochondrial antibody in patients with primary biliary cirrhosis. Clin Dev Immunol 2004;11:129\u201333","journal-title":"Clin Dev Immunol"},{"key":"9326_CR10","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1055\/s-2005-916321","volume":"25","author":"P Innervizzi","year":"2005","unstructured":"Innervizzi P, Selmi C, Ranftler C, Podda M, Wesierska-Gadek J. Antinuclear antibodies in primary biliary cirrhosis. Semin Liver Dis 2005;25:298\u2013310","journal-title":"Semin Liver Dis"},{"key":"9326_CR11","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1002\/hep.21472","volume":"45","author":"M Nakamura","year":"2007","unstructured":"Nakamura M, Kondo H, Mori T, Komori A, Matsuyana M, Ito M, et al. Anti GP 210 and anticentromeric antibodies are different risk factors for progression of primary biliary cirrhosis. Hepatology 2007;45:118\u2013127","journal-title":"Hepatology"},{"key":"9326_CR12","doi-asserted-by":"crossref","first-page":"3292","DOI":"10.3748\/wjg.14.3292","volume":"14","author":"IR Mackay","year":"2008","unstructured":"Mackay IR. Historical reflections on autoimmune hepatitis. World J Gastroenterol 2008;14:3292\u20133300","journal-title":"World J Gastroenterol"},{"key":"9326_CR13","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1056\/NEJMra050408","volume":"354","author":"EL Krawitt","year":"2006","unstructured":"Krawitt EL. Autoimmune hepatitis. N Engl J Med 2006;354:54\u201366","journal-title":"N Engl J Med"},{"key":"9326_CR14","doi-asserted-by":"crossref","first-page":"1502","DOI":"10.1053\/gast.2001.24227","volume":"120","author":"MP Manns","year":"2001","unstructured":"Manns MP, Strassburg CP. Autoimmune hepatitis: clinical challenges. Gasteroenterology 2001;120:1502\u20131517","journal-title":"Gasteroenterology"},{"key":"9326_CR15","doi-asserted-by":"crossref","first-page":"1244","DOI":"10.1111\/j.1572-0241.2007.01136.x","volume":"102","author":"MG Silveira","year":"2007","unstructured":"Silveira MG, Talwalker JA, Angulo P, Lindor K. Overlap of autoimmune hepatitis and primary biliary cirrhosis: long-term outcomes. Am J Gasteroenterol 2007;102:1244\u20131250","journal-title":"Am J Gasteroenterol."},{"key":"9326_CR16","doi-asserted-by":"crossref","first-page":"3368","DOI":"10.3748\/wjg.14.3368","volume":"14","author":"P Invernizzi","year":"2008","unstructured":"Invernizzi P, Mackay IR. Overlap syndrome among autoimmune liver diseases. World J Gasteroenterol 2008;14:3368\u20133373","journal-title":"World J Gasteroenterol"},{"key":"9326_CR17","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1002\/hep.22906","volume":"50","author":"KD Lindor","year":"2009","unstructured":"Lindor KD, Gershwin ME, Poupon R, Kaplan M, Bergasa NV, Heathcoate EJ. Primary biliary cirrhosis. AASLD practice guidelines. Hepatology 2009;50:291\u2013308","journal-title":"Hepatology"},{"key":"9326_CR18","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1002\/hep.510280210","volume":"28","author":"AJ Czaja","year":"1998","unstructured":"Czaja AJ. Frequency and nature of the variant forms of autoimmune liver disease. Hepatology 1998;28:360\u2013365","journal-title":"Hepatology"},{"key":"9326_CR19","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1002\/hep.22380","volume":"48","author":"C O\u2019Brien","year":"2008","unstructured":"O\u2019Brien C, Joshi S, Feld JJ, Guindi M, Dienes HP, Heathcoate EJ. Long-term follow up of antimitochondrial antibody positive autoimmune hepatitis. Hepatology 2008;48:550\u2013556","journal-title":"Hepatology"},{"key":"9326_CR20","first-page":"105","volume":"5","author":"SK Sarin","year":"2006","unstructured":"Sarin SK, Monga R, Sandhu BS, Sharma BC, Sakhuja P, Malhotra V. Primary biliary cirrhosis in India. Hepatobiliary Pancreat Dis Int 2006;5:105\u2013109","journal-title":"Hepatobiliary Pancreat Dis Int"},{"key":"9326_CR21","first-page":"A50","volume":"23","author":"RW Minz","year":"2004","unstructured":"Minz RW, Anand S, Bhasin DK, Sood S, Das A, Bhansali A, Dhiman RK, Chawla YK. Rising annual detection of antimitochondrial antibody (AMA) in liver disease in north India. Indian J Gastroenterol 2004;23:A50","journal-title":"Indian J Gastroenterol"},{"key":"9326_CR22","doi-asserted-by":"crossref","first-page":"7491","DOI":"10.1186\/1757-1626-2-7491","volume":"2","author":"RW Minz","year":"2009","unstructured":"Minz RW, Chhabra S, Aggarwal R, Das A, Saikia B, Chawla YK. Incipient primary biliary cirrhosis\/autoimmune hepatitis overlap or hepatitic form of primary biliary cirrohosis: a case report. Cases J 2009;2:7491","journal-title":"Cases J"},{"key":"9326_CR23","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1186\/1740-2557-4-3","volume":"4","author":"PA Papamichalis","year":"2007","unstructured":"Papamichalis PA, Zachou K, Koukkoulis GK, Veloni A, Karacosta EG, Kypri L, et al. The revised international autoimmune hepatitis score in chronic liver diseases including autoimmune hepatitis\/overlap syndrome and autoimmune hepatitis with concurrent other liver disorders. J Autoimmun Dis 2007;4:3","journal-title":"J Autoimmun Dis"},{"key":"9326_CR24","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1002\/hep.510280203","volume":"28","author":"O Chazouilleres","year":"1998","unstructured":"Chazouilleres O, Wendum D, Serfaty L, Montembault S, Rosmorduc O, Poupon R. Primary Biliary Cirrhosis\u2013autoimmune hepatitis overlap syndrome. Clinical features and response to therapy. Hepatology 1998;28:296\u2013301","journal-title":"Hepatology"},{"key":"9326_CR25","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1002\/hep.22322","volume":"48","author":"EM Hennes","year":"2008","unstructured":"Hennes EM, Zeniya M, Czaja AJ, Pares A, Dalekos GN, Krawitt EL, et al. Simplified criteria for the diagnosis of autoimmune hepatitis. Hepatology 2008;48:169\u2013176","journal-title":"Hepatology"},{"key":"9326_CR26","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1136\/gut.14.6.448","volume":"14","author":"AKS Samanta","year":"1973","unstructured":"Samanta AKS, Bhagwat AG, Mukherjee M, Gupta NM, Sehgal S, Datta DV. Primary biliary cirrhosis in India: a case report. Gut 1973;14:448\u2013450","journal-title":"Gut"},{"key":"9326_CR27","doi-asserted-by":"crossref","first-page":"588","DOI":"10.7326\/0003-4819-125-7-199610010-00009","volume":"125","author":"AJ Czaja","year":"1996","unstructured":"Czaja AJ. The variant forms of autoimmune hepatitis. Ann Intern Med 1996;125:588\u2013598","journal-title":"Ann Intern Med"},{"key":"9326_CR28","doi-asserted-by":"crossref","first-page":"1078","DOI":"10.1002\/hep.510290409","volume":"29","author":"AW Lohse","year":"1999","unstructured":"Lohse AW, Meyer zum Buschenfelde KH MZ, Franz B, Kanzler S, Gerken G, Dienes HP. Characterization of the overlap syndrome of primary biliary cirrhosis (PBC) and autoimmune hepatitis: evidence of it being a hepatitic form of primary biliary cirrhosis in generally susceptible individuals. Hepatology 1999;29:1078\u20131084","journal-title":"Hepatology"},{"key":"9326_CR29","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1016\/S0168-8278(02)00440-3","volume":"38","author":"P Invernizzi","year":"2003","unstructured":"Invernizzi P, Battezzati PM, Crosignani A, Perego F, Poli F, Morabito A, et al. Peculiar HLA polymorphisms in Italian patients with primary biliary cirrhosis. J Hepatol 2003;38:401\u2013406","journal-title":"J Hepatol"},{"key":"9326_CR30","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/j.cld.2008.02.007","volume":"12","author":"BD Juran","year":"2008","unstructured":"Juran BD, Lazaridis KN. Genetics and genomics of primary biliary cirrhosis. Clin Liver Dis 2008;12:349\u2013365","journal-title":"Clin Liver Dis"},{"key":"9326_CR31","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1002\/hep.21316","volume":"44","author":"PT Donaldson","year":"2006","unstructured":"Donaldson PT, Baragiotta A, Heneghan MA, Floreani A, Venturi C, Underhill JA, et al. HLA class II alleles, genotypes, haplotypes and amino acids in primary biliary cirrhosis: a large scale study. Hepatology 2006;44:667\u201374","journal-title":"Hepatology"},{"key":"9326_CR32","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/S0168-8278(01)00237-9","volume":"36","author":"J Stone","year":"2002","unstructured":"Stone J, Wade JA, Cauch-Dudek K, Ng C, Lindor KD, Heathcoate EJ. Human leucocyte antigen class II associations in serum antimitochondrial antibodies (AMAs)-positive and AMA negative primary biliary cirrhosis. J Hepatol 2002;36:8\u201313","journal-title":"J Hepatol"},{"key":"9326_CR33","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1111\/j.1399-0039.2005.00351.x","volume":"65","author":"ME Mullarkey","year":"2005","unstructured":"Mullarkey ME, Stevens AM, Mc Donnell WM, Loubiere LS, Brackensick JA, Pang JM, et al. Human leukocyte antigen class II alleles in Caucasian women with primary biliary cirrhosis. Tissue Antigens 2005;65:199\u2013205","journal-title":"Tissue Antigens"},{"key":"9326_CR34","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1111\/j.1399-0039.1994.tb02303.x","volume":"43","author":"AB Begovich","year":"1994","unstructured":"Begovich AB, Klitz W, Moonsamy PV, Van de Water J, Peltz G, Gershwin ME. Genes within HLA class II region confer both predisposition and resistance to primary biliary cirrhosis. Tissue Antigens 1994;43:71\u201377","journal-title":"Tissue Antigens"},{"key":"9326_CR35","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1016\/S0168-8278(05)80617-8","volume":"21","author":"R Wassmuth","year":"1994","unstructured":"Wassmuth R, Depner F, Danielson A, Hultcrantz R, Loof L, Olson R, et al. HLA class II markers and clinical heterogeneity in Swedish patients with primary biliary cirrhosis. J Hepatol 1994;21:1053\u20131060","journal-title":"J Hepatol"},{"key":"9326_CR36","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1111\/j.1872-034X.2010.00631.x","volume":"40","author":"M Nakamura","year":"2010","unstructured":"Nakamura M, Yasunami M, Kondo H, Horie H, Aiba Y, Komori A, et al. Analysis of HLA-DRB1 polymorphisms in Japanese patients with primary biliary cirrhosis (PBC): the HLA-DRB1 polymorphism determines the relative risk of antinuclear antibodies for disease progression in PBC. Hepatology Research 2010;40:494\u2013504","journal-title":"Hepatology Research"},{"key":"9326_CR37","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1002\/hep.1840180113","volume":"18","author":"T Seki","year":"1993","unstructured":"Seki T, Kiyosawa K, Ota M, Furuta S, Fukushima H, Tanaka E, et al. Association of primary biliary cirrhosis with human leucocyte antigen DPB1*0501 in Japanese patients. Hepatology 1993;18:73\u201378","journal-title":"Hepatology"},{"key":"9326_CR38","first-page":"129","volume":"5","author":"HY Liu","year":"2006","unstructured":"Liu HY, Deng AM, Zhou Y, Yao DK, Xu DX, Zhong RQ. Analysis of HLA alleles polymorphism in Chinese patients with primary biliary cirrhosis. Hepatobiliary Pancreat Dis Int 2006;5:129\u2013132","journal-title":"Hepatobiliary Pancreat Dis Int"},{"key":"9326_CR39","doi-asserted-by":"crossref","first-page":"2544","DOI":"10.1056\/NEJMoa0810440","volume":"360","author":"GM Hirschfield","year":"2009","unstructured":"Hirschfield GM, Liu X, Xu C, Lu Y, Xie G, Lu Y, et al. Primary Biliary Cirrhosis associated with HLA, ILI2A, and IL12RB2 variants. N Engl J Med 2009;360:2544\u201355.","journal-title":"N Engl J Med"},{"key":"9326_CR40","doi-asserted-by":"crossref","unstructured":"Indian genome consortium. Genetic landscape of the people of India: A canvas for disease gene exploration. J Genet 2008;87:3\u201320","DOI":"10.1007\/s12041-008-0002-x"}],"container-title":["Hepatology International"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12072-011-9326-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12072-011-9326-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12072-011-9326-3","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,6,28]],"date-time":"2020-06-28T15:55:13Z","timestamp":1593359713000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12072-011-9326-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,12,11]]},"references-count":40,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2012,10]]}},"alternative-id":["9326"],"URL":"https:\/\/doi.org\/10.1007\/s12072-011-9326-3","relation":{},"ISSN":["1936-0533","1936-0541"],"issn-type":[{"value":"1936-0533","type":"print"},{"value":"1936-0541","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,12,11]]}}}